Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Recombinant Newcastle disease viruses expressing immunological checkpoint inhibitors induce a pro-inflammatory state and enhance tumor-specific immune responses in two murine models of cancer.
Santry LA, van Vloten JP, AuYeung AWK, Mould RC, Yates JGE, McAusland TM, Petrik JJ, Major PP, Bridle BW, Wootton SK. Santry LA, et al. Among authors: van vloten jp. Front Microbiol. 2024 Jan 24;15:1325558. doi: 10.3389/fmicb.2024.1325558. eCollection 2024. Front Microbiol. 2024. PMID: 38328418 Free PMC article.
Combining vanadyl sulfate with Newcastle disease virus potentiates rapid innate immune-mediated regression with curative potential in murine cancer models.
McAusland TM, van Vloten JP, Santry LA, Guilleman MM, Rghei AD, Ferreira EM, Ingrao JC, Arulanandam R, Major PP, Susta L, Karimi K, Diallo JS, Bridle BW, Wootton SK. McAusland TM, et al. Among authors: van vloten jp. Mol Ther Oncolytics. 2021 Jan 21;20:306-324. doi: 10.1016/j.omto.2021.01.009. eCollection 2021 Mar 26. Mol Ther Oncolytics. 2021. PMID: 33614913 Free PMC article.
Enhancing Immune Responses to Cancer Vaccines Using Multi-Site Injections.
Mould RC, AuYeung AWK, van Vloten JP, Susta L, Mutsaers AJ, Petrik JJ, Wood GA, Wootton SK, Karimi K, Bridle BW. Mould RC, et al. Among authors: van vloten jp. Sci Rep. 2017 Aug 16;7(1):8322. doi: 10.1038/s41598-017-08665-9. Sci Rep. 2017. PMID: 28814733 Free PMC article.
Quantifying Antibody Responses Induced by Antigen-Agnostic Immunotherapies.
van Vloten JP, Klafuric EM, Karimi K, McFadden G, Petrik JJ, Wootton SK, Bridle BW. van Vloten JP, et al. Mol Ther Methods Clin Dev. 2019 Jul 12;14:189-196. doi: 10.1016/j.omtm.2019.06.010. eCollection 2019 Sep 13. Mol Ther Methods Clin Dev. 2019. PMID: 31388514 Free PMC article.
Tumour vasculature: Friend or foe of oncolytic viruses?
Santry LA, van Vloten JP, Knapp JP, Matuszewska K, McAusland TM, Minott JA, Mould RC, Stegelmeier AA, Major PP, Wootton SK, Petrik JJ, Bridle BW. Santry LA, et al. Among authors: van vloten jp. Cytokine Growth Factor Rev. 2020 Dec;56:69-82. doi: 10.1016/j.cytogfr.2020.07.007. Epub 2020 Sep 1. Cytokine Growth Factor Rev. 2020. PMID: 32893095 Review.
Using a Prime-Boost Vaccination Strategy That Proved Effective for High Resolution Epitope Mapping to Characterize the Elusive Immunogenicity of Survivin.
Mould RC, van Vloten JP, AuYeung AWK, Walsh SR, de Jong J, Susta L, Mutsaers AJ, Petrik JJ, Wood GA, Wootton SK, Karimi K, Bridle BW. Mould RC, et al. Among authors: van vloten jp. Cancers (Basel). 2021 Dec 14;13(24):6270. doi: 10.3390/cancers13246270. Cancers (Basel). 2021. PMID: 34944889 Free PMC article.
24 results